SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Needham Initiates Coverage On Haemonetics with Buy Rating, Announces $138 Price Target

Needham analyst Mike Matson initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and a $138 price target.

Benzinga · -

Needham analyst Mike Matson initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and a $138 price target.